Efficacy of Zidovudine Compared to Stavudine, Both in Combination with Lamivudine and Indinavir, in Human Immunodeficiency Virus-Infected Nucleoside-Experienced Patients with No Prior Exposure to Lamivudine, Stavudine, or Protease Inhibitors (Novavir Trial)

We compared the efficacy and the toxicity of zidovudine (AZT) versus stavudine (d4T), in combination with lamivudine (3TC) and indinavir, in AZT-, dideoxyinosine (ddI)-, and/or dideoxycytosine (ddC)-experienced patients in a randomized comparative multicenter trial. One hundred seventy human immunod...

Szczegółowa specyfikacja

Zapisane w:

Opis bibliograficzny
Wydane w:	Antimicrob Agents Chemother
Główni autorzy:	Joly, Véronique, Flandre, Philippe, Meiffredy, Vincent, Brun-Vezinet, Françoise, Gastaut, Jean-Albert, Goujard, Cécile, Remy, Gérard, Descamps, Diane, Ruffault, Annick, Certain, Agnès, Aboulker, Jean-Pierre, Yeni for the Novavir Study Group, Patrick
Format:	Artigo
Język:	Inglês
Wydane:	American Society for Microbiology (ASM) 2002
Hasła przedmiotowe:	Antiviral Agents
Dostęp online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127263/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12019107/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.6.1906-1913.2002
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Efficacy of Zidovudine Compared to Stavudine, Both in Combination with Lamivudine and Indinavir, in Human Immunodeficiency Virus-Infected Nucleoside-Experienced Patients with No Prior Exposure to Lamivudine, Stavudine, or Protease Inhibitors (Novavir Trial)

Podobne zapisy